NARATIVE REVIEW: POTENSI INULIN UMBI DAHLIA SEBAGAI ANTI DIABETES

Authors

  • Sunarti Sunarti Universitas Prima Indonesia
  • Chrismis Novalinda Ginting Universitas Prima Indonesia
  • Sahna Ferdinand Ginting Universitas Prima Indonesia

DOI:

https://doi.org/10.34012/jukep.v5i1.2134

Keywords:

Inulin, diabetes, diet rendah serat

Abstract

Inulin is a type of polysaccharide that is commonly found in nature derived from the dahlia tuber plant, and other plants such as chicory, Jerusalem artichoke, Yaco´n potato and asparagus. Inulin is widely used in industry and pharmaceuticals. In the industrial world, inulin is used as a source of natural sweetener, enhances the taste of food, ferments, and is a low-fiber food source. While in the pharmaceutical world, inulin can be used in several studies, one of which is as an anti-diabetic. This study aims to determine the potential of dahlia tuber inulin as an anti-diabetic. The type of research is a narrative review. Search data using three databases, namely Elsevier (SCOPUS), Pubmed and Google Scholar with a limitation of the last 10 years of articles with the keyword "inulin for diabetes", with the PRISMA method. The results showed that inulin works on glucose absorption in the intestine, lowers blood sugar levels, lowers hemoglobin A1c, increases circulating GLP-1, reduces hyperglycemia, reduces insulin resistance (IR) and hyperlipidemia, reduces oxidative stress, increases insulin and leptin levels, facilitates glucose transport of GLUT4 by activating the PI3K/Akt pathway, is anti-inflammatory, and is involved in the expression of several anti-hyperglycemic genes. The conclusion is that dahlia tuber inulin has an anti-diabetic effect.

Downloads

Published

2022-01-04

How to Cite

Sunarti, S., Ginting, C. N., & Ginting, S. F. (2022). NARATIVE REVIEW: POTENSI INULIN UMBI DAHLIA SEBAGAI ANTI DIABETES. Jurnal Keperawatan Priority, 5(1), 53-65. https://doi.org/10.34012/jukep.v5i1.2134

Issue

Vol. 5 No. 1 (2022)

Section

Articles

License

Copyright (c) 2022 Sunarti Sunarti, Chrismis Novalinda Ginting, Sahna Ferdinand Ginting

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish their manuscripts through the Journal of Keperawatan Priority agree to the following:

  • Copyright to the manuscripts of scientific papers in this Journal is held by the author.
  • The author surrenders the rights when first publishing the manuscript of his scientific work and simultaneously the author grants permission / license by referring to the Creative Commons Attribution 4.0 International License to other parties to distribute his scientific work while still giving credit to the author and the Journal of Journal Keperawatan Priority as the first publication medium for the work.
  • Matters relating to the non-exclusivity of the distribution of the Journal that publishes the author's scientific work can be agreed separately (for example: requests to place the work in the library of an institution or publish it as a book) with the author as one of the parties to the agreement and with credit to sJournal ofJournal Keperawatan Priority as the first publication medium for the work in question.
  • Authors can and are expected to publish their work online (e.g. in a Repository or on their Organization's/Institution's website) before and during the manuscript submission process, as such efforts can increase citation exchange earlier and with a wider scope.